WebApr 15, 2024 · The company had revenue of $107.20 million for the quarter, compared to analyst estimates of $108.23 million. Ironwood Pharmaceuticals had a net margin of 42.64% and a return on equity of 30.49%. Ironwood Pharmaceuticals’s revenue for the quarter was down 8.5% on a year-over-year basis. During the same quarter last year, the firm posted … WebFeb 17, 2024 · Michael Dabaie Ironwood Pharmaceuticals Inc. reported fourth quarter revenue and adjusted earnings above analyst expectations. Fourth quarter total revenue came to $116.7 million, down from...
Ironwood Pharmaceuticals Company Profile - Craft
WebApr 6, 2024 · Ironwood Pharmaceuticals, Inc. is a gastrointestinal (GI) healthcare company, which is advancing the treatment of GI diseases and redefining the standard of care for GI patients. It is develops and commercializes GI product opportunities in areas of significant unmet need, leveraging its demonstrated expertise and capabilities in GI diseases. WebFeb 17, 2024 · Ironwood Pharmaceuticals Inc. reported fourth quarter revenue and adjusted earnings above analyst expectations. Fourth quarter total revenue came to $116.7 million, … mounted crow
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Sold by …
WebApr 14, 2024 · Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Rating) was the recipient of unusually large options trading activity on Thursday. ... The company had revenue of $107.20 million for the ... WebIronwood Pharmaceuticals, headquartered in Boston, Massachusetts, and established in 1998, is a specialty and generic drug manufacturing company specializing in … WebFeb 16, 2024 · Ironwood Pharmaceuticals (IRWD) came out with quarterly earnings of $0.27 per share, missing the Zacks Consensus Estimate of $0.28 per share. This compares to … heart food bank reynoldsburg ohio